Pura Vida Investments’s Orchestra BioMed OBIO Stock Holding History

Pura Vida Investments’s Portfolio OBIO Stock Details OBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-104,026	Closed	-$1.04M	–	237
2022 Q2	$1.04M	Hold	104,026	–	–	0.06%	166
2022 Q1	$1.03M	Buy	104,026 +500	+0.5%	+$4.94K	0.03%	184
2021 Q4	$1.04M	Sell	103,526 -2,776	-3%	-$27.4K	0.04%	178
2021 Q3	$1.05M	Sell	106,302 -1,616	-1%	-$16K	0.03%	217
2021 Q2	$1.1M	Sell	107,918 -1,574	-1%	-$16.3K	0.03%	178
2021 Q1	$1.23M	Buy	109,492 +9,492	+9%	+$116K	0.03%	186
2020 Q4	$1.28M	Hold	100,000	–	–	0.05%	158
2020 Q3	$1.1M	Buy	+100,000	New	+$1.12M	0.06%	128

Other funds holding OBIO

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Pura Vida Investments's OBIO Position: Q3 2022 in Review

Pura Vida Investments sold out of Orchestra BioMed (OBIO) in Q3 2022, closing a stake of 104,026 shares — an estimated $1.04M sold.

Pura Vida Investments first reported a position in OBIO in Q3 2020 and held it in 8 quarters. The position peaked at $1.28M in Q4 2020. 23 funds tracked by Wall St. Rank hold OBIO as of Q3 2022.

Pura Vida Investments reported no remaining Orchestra BioMed position as of Q3 2022 after selling out during the quarter.
Pura Vida Investments sold 104,026 Orchestra BioMed shares in Q3 2022, an estimated $1.04M.
Pura Vida Investments first reported a position in Orchestra BioMed in Q3 2020 and held it in 8 quarters.
Pura Vida Investments's Orchestra BioMed position peaked at $1.28M in Q4 2020.
23 funds tracked by Wall St. Rank held Orchestra BioMed as of Q3 2022.

Based on Pura Vida Investments's 13F filing for Q3 2022, filed 14 Nov 2022.